{
    "2019-11-12": [
        [
            {
                "time": "2020-11-13",
                "original_text": "Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Pfizer",
                        "Viatris",
                        "Combination"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-28",
                "original_text": "Pfizer Announces Results of Phase 3 Study for XELJANZÂ® (tofacitinib) in Juvenile Idiopathic Arthritis Ahead of Presentation at 2019 American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "XELJANZ",
                        "Phase 3",
                        "Study Results",
                        "Juvenile Idiopathic Arthritis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}